Cargando…
Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line
BACKGROUND: Mucosal melanoma has characteristically distinct genetic features and typically poor prognosis. The lack of representative mucosal melanoma models, especially cell lines, has hindered translational research on this melanoma subtype. In this study, we aimed to establish and provide the bi...
Autores principales: | Shi, Chaoji, Gu, Ziyue, Xu, Shengming, Ju, Houyu, Wu, Yunteng, Han, Yong, Li, Jiayi, Li, Chuwen, Wu, Jing, Wang, Lizhen, Li, Jiang, Zhou, Guoyu, Ye, Weimin, Ren, Guoxin, Zhang, Zhiyuan, Zhou, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257989/ https://www.ncbi.nlm.nih.gov/pubmed/35666052 http://dx.doi.org/10.1002/cac2.12315 |
Ejemplares similares
-
The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China
por: Ma, Xuhui, et al.
Publicado: (2017) -
Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma
por: Gu, Ziyue, et al.
Publicado: (2022) -
Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases
por: Ma, Xuhui, et al.
Publicado: (2017) -
Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017) -
Cisplatin based induction chemotherapy modified by ERCC1 improved the outcome of young adults with locally advanced oral squamous cell carcinoma
por: Gong, Yin, et al.
Publicado: (2019)